Protective effects of long term antiplatelet and anticoagulant therapy in hospitalized patients with inflammatory bowel disease

Table 2 Outcomes of hospitalization stratified into four groups based on use of antiplatelet/anticoagulant agents (n = 374744), n (%)

Outcomes	No drug therapy	Antiplatelet therapy	Anticoagulant therapy	Antiplatelet and anticoagulant therapy	P value
Mortality	0.27	0.42	0.62	0.75	0.0016
LOS (days)	4.91	5.01	5.87	5.61	< 0.001
TPN	2.23	1.59	3.33	2.74	0.0001
AKI	7.33	16.13	15.2	21.14	< 0.001
Sepsis	2.0	1.27	1.47	1.24	0.0025
Shock	0.7	1.22	1.55	4.48	< 0.001
Colonoscopy	23.37	27.8	25.96	33.33	< 0.001
Lower GI bleed	3.04	3.95	5.34	6.72	< 0.001
Non variceal Upper GI bleed	0.81	0.95	1.04	1.49	0.1905
Abdominal surgery	10.05	7.53	9.13	5.47	< 0.001
Total charge ($)	46800	45978	54912	50569	< 0.001
Home or home health care	92.84	88.17	86.69	82.84	< 0.001
Short term hospital	1.55	1.03	1.70	1.53	< 0.001
SNF or other facility	2.98	9.52	9.48	13.93	< 0.001

LOS: Length of stay; TPN: Total parenteral nutrition; AKI: Acute kidney injury; GI: Gastrointestinal; SNF: Skilled nursing facility.